Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Short-term Intensive De-escalation Therapeutic Strategy on Long-term Regimen Simplification in Poorly Controlled Type 2 Diabetes
NCT03958591Phase 4Completed
- Start
- May 2019
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in type 2 diabetes mellitus (T2DM). Started May 2019; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03958591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03958591.